Litcius/Paper detail

The development of an electrochemical immunosensor utilizing chicken IgY anti-spike antibody for the detection of SARS-CoV-2

Khaled M. Al-Qaoud, Yusra Obeidat, Tareq Al-Omari, Mohammad Khaleel Okour, Mariam Al-Omari, Mohammad I. Ahmad, Raed Alshadfan, Abdel‐Monem M. Rawashdeh

2024Scientific Reports24 citationsDOIOpen Access PDF

Abstract

This paper introduces a novel approach for detecting the SARS-CoV-2 recombinant spike protein combining a label free electrochemical impedimetric immunosensor with the use of purified chicken IgY antibodies. The sensor employs three electrodes and is functionalized with an anti-S IgY antibody, ELISA and immunoblot assays confirmed the positive response of chicken immunized with SARS-CoV2 S antigen. The developed immunosensor is effective in detecting SARS-CoV-2 in nasopharyngeal clinical samples from suspected cases. The key advantage of this biosensor is its remarkable sensitivity, and its capability of detecting very low concentrations of the target analyte, with a detection limit of 5.65 pg/mL. This attribute makes it highly suitable for practical point-of-care (POC) applications, particularly in low analyte count clinical scenarios, without requiring amplification. Furthermore, the biosensor has a wide dynamic range of detection, spanning from 11.56 to 740 ng/mL, which makes it applicable for sample analysis in a typical clinical setting.

Topics & Concepts

AnalyteDetection limitBiosensorChromatographyAntibodyRecombinant DNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Specific antibodyImmunoassayCoronavirus disease 2019 (COVID-19)ChemistryVirologyMedicineImmunologyBiochemistryInfectious disease (medical specialty)PathologyDiseaseGeneSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchAdvanced biosensing and bioanalysis techniques